When was IM Biologics founded?

IM Biologics was founded in 2020.

Where is IM Biologics headquartered?

IM Biologics is headquartered in Suwon, South Korea.

What industry is IM Biologics in?

IM Biologics operates in Biotech, Healthcare.

How many employees does IM Biologics have?

IM Biologics has 11-50 employees.

IM Biologics

Innovative Medicines based on ImmunoModulatory Biologics

Suwon, South Korea · Founded 2020

Biotech

Healthcare

Headquarters: Suwon
Employees: 11–50
Founded: 2020

Business Model: B2B
Website: imbiologics.com

About

IMBiologics (IMB) is a South Korean biopharmaceutical company founded in August 2020, dedicated to developing innovative antibody-based therapeutics for immunology, inflammation, and oncology. Leveraging its proprietary IM-OpDECon antibody modality engineering platform, IMB designs differentiated biologics targeting autoimmune diseases and immuno-oncology with unmet medical needs. The company is headquartered in Suwon, Gyeonggi-do, Korea, and is listed on the KOSDAQ exchange, having achieved a landmark $944.8 million global licensing deal for its lead asset IMB-101.

Summary

IM Biologics is a Biotech company based in Suwon, South Korea, founded in 2020.